| Alberta L Wang, MD | |
|
Pediatric Pulmonary And Allergy, 725 Albany Street , Shapiro 8, Boston, MA 02118 | |
| (617) 414-4841 | |
| Not Available |
| Full Name | Alberta L Wang |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 12 Years |
| Location | Pediatric Pulmonary And Allergy, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588927263 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 270118 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brigham And Women's Physicians Organization Inc | 3870405988 | 2510 |
News Archive
"The government in Pakistan's eastern province of Punjab is struggling to control a growing dengue fever epidemic, officials say," and they "have warned that it threatens to affect other parts of the country," BBC News reports.
Matrixx Initiatives, Inc. and H.I.G. Capital, LLC ("H.I.G."), a leading global private investment firm, today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to the previously announced acquisition of all outstanding shares of common stock of the Company by affiliates of H.I.G. Accordingly, the condition with respect to the expiration of the applicable waiting periods under the HSR Act has been satisfied.
As October 1, 2009 signals the beginning of the new fiscal year 2010, the American Health Care Association (AHCA) said cuts of up to $16 billion over ten years to Medicare funded nursing home care being put into effect today by the Centers for Medicare and Medicaid Services (CMS) must be taken into account by U.S. Senate and House leaders as they continue to refine the financing details of their respective health care reform bills.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd. ("Ascentage Pharma") announced today that they have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis. The alliance will leverage Ascentage Pharma's expertise in structure-based small molecule design, lead optimization and preclinical development with 3SBio's proven drug development and commercialization capabilities in China.
› Verified 8 days ago
| Entity Name | Dana-farber Cancer Institute, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851333686 PECOS PAC ID: 9133038904 Enrollment ID: O20040223000228 |
News Archive
"The government in Pakistan's eastern province of Punjab is struggling to control a growing dengue fever epidemic, officials say," and they "have warned that it threatens to affect other parts of the country," BBC News reports.
Matrixx Initiatives, Inc. and H.I.G. Capital, LLC ("H.I.G."), a leading global private investment firm, today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to the previously announced acquisition of all outstanding shares of common stock of the Company by affiliates of H.I.G. Accordingly, the condition with respect to the expiration of the applicable waiting periods under the HSR Act has been satisfied.
As October 1, 2009 signals the beginning of the new fiscal year 2010, the American Health Care Association (AHCA) said cuts of up to $16 billion over ten years to Medicare funded nursing home care being put into effect today by the Centers for Medicare and Medicaid Services (CMS) must be taken into account by U.S. Senate and House leaders as they continue to refine the financing details of their respective health care reform bills.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd. ("Ascentage Pharma") announced today that they have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis. The alliance will leverage Ascentage Pharma's expertise in structure-based small molecule design, lead optimization and preclinical development with 3SBio's proven drug development and commercialization capabilities in China.
› Verified 8 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
"The government in Pakistan's eastern province of Punjab is struggling to control a growing dengue fever epidemic, officials say," and they "have warned that it threatens to affect other parts of the country," BBC News reports.
Matrixx Initiatives, Inc. and H.I.G. Capital, LLC ("H.I.G."), a leading global private investment firm, today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to the previously announced acquisition of all outstanding shares of common stock of the Company by affiliates of H.I.G. Accordingly, the condition with respect to the expiration of the applicable waiting periods under the HSR Act has been satisfied.
As October 1, 2009 signals the beginning of the new fiscal year 2010, the American Health Care Association (AHCA) said cuts of up to $16 billion over ten years to Medicare funded nursing home care being put into effect today by the Centers for Medicare and Medicaid Services (CMS) must be taken into account by U.S. Senate and House leaders as they continue to refine the financing details of their respective health care reform bills.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd. ("Ascentage Pharma") announced today that they have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis. The alliance will leverage Ascentage Pharma's expertise in structure-based small molecule design, lead optimization and preclinical development with 3SBio's proven drug development and commercialization capabilities in China.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alberta L Wang, MD 720 Harrison Ave # Dob503, Boston, MA 02118-2371 Ph: (617) 414-5405 | Alberta L Wang, MD Pediatric Pulmonary And Allergy, 725 Albany Street , Shapiro 8, Boston, MA 02118 Ph: (617) 414-4841 |
News Archive
"The government in Pakistan's eastern province of Punjab is struggling to control a growing dengue fever epidemic, officials say," and they "have warned that it threatens to affect other parts of the country," BBC News reports.
Matrixx Initiatives, Inc. and H.I.G. Capital, LLC ("H.I.G."), a leading global private investment firm, today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to the previously announced acquisition of all outstanding shares of common stock of the Company by affiliates of H.I.G. Accordingly, the condition with respect to the expiration of the applicable waiting periods under the HSR Act has been satisfied.
As October 1, 2009 signals the beginning of the new fiscal year 2010, the American Health Care Association (AHCA) said cuts of up to $16 billion over ten years to Medicare funded nursing home care being put into effect today by the Centers for Medicare and Medicaid Services (CMS) must be taken into account by U.S. Senate and House leaders as they continue to refine the financing details of their respective health care reform bills.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd. ("Ascentage Pharma") announced today that they have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis. The alliance will leverage Ascentage Pharma's expertise in structure-based small molecule design, lead optimization and preclinical development with 3SBio's proven drug development and commercialization capabilities in China.
› Verified 8 days ago
Dr. David H. Sachs, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: Bldg. 149-9019, 13th Street, Boston, MA 02466 Phone: 617-726-4065 Fax: 617-726-4067 | |
Dr. Anne Esther Goldfeld, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 800 Huntington Ave, Boston, MA 02115 Phone: 617-278-3351 Fax: 617-278-3454 | |
Dr. Sachin Niranjan Baxi, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Fegan 6, Boston, MA 02115 Phone: 617-919-2489 Fax: 617-730-0310 | |
Dr. Richard Arthur Moscicki, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 15 Parkman St, Allergy Associates Wac 626, Boston, MA 02114 Phone: 617-726-3764 Fax: 617-252-7694 | |
Abduarahmn Almutairi, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6117 | |
John L Ohman, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 750 Washington St, Nemc Box 30, Boston, MA 02111 Phone: 617-636-5000 Fax: 617-636-4843 | |
Dr. Paul J. Maglione, MD, PHD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 725 Albany St, Shapiro 9 Suite B, Boston, MA 02118 Phone: 617-638-7480 |